Table 1.
Demographic and comorbidity data in the entire cohort.
| Entire cohort | HIV-positive | HIV-negative | p value | |
|---|---|---|---|---|
| (n=384) | (n = 108) | (n = 276) | ||
| Age | ||||
| Median (IQR), (years) | 50 (39–60) | 45 (38–56) | 52.5 (39.8–61) | 0.008 |
| Gender | ||||
| n (%) | ||||
| Male | 204 (53%) | 54 (50%) | 150 (54%) | 0.50 |
| Female | 180 (47%) | 54 (50%) | 126 (46%) | |
| Race | ||||
| n (%) | ||||
| Black | 322 (84%) | 100 (92.6%) | 222 (80.4%) | |
| White | 27 (7%) | 6 (5.6%) | 21 (7.6%) | |
| Indian | 10 (3%) | 1 (0.9%) | 24 (8.7%) | |
| Mixed race | 25 (6%) | 1 (0.9%) | 9 (3.3%) | |
| Comorbidities | ||||
| n (%) | ||||
| Cardiovascular disease | 148 (39%) | 36 (33.3%) | 112 (40.6%) | 0.20 |
| Chronic kidney disease | 35 (9%) | 10 (9.26%) | 25 (9.06%) | 1.0 |
| Chronic liver disease | 6 (2%) | 2 (1.85%) | 4 (1.45%) | 0.68 |
| Chronic lung disease | 16 (4%) | 6 (5.56%) | 10 (3.62%) | 0.40 |
| Tuberculosis | 14 (4%) | 8 (7.41%) | 6 (2.17%) | 0.03 |
| Diabetes mellitus | 88 (23%) | 18 (16.67%) | 70 (25.46%) | 0.08 |
| Dyslipidaemia | 15 (4%) | 4 (16.67%) | 11 (25.36%) | 0.08 |
| Obesity | 60 (16%) | 13 (12.04%) | 47 (17.03%) | 0.27 |
| Thyroid disease | 6 (1.56%) | 1 (0.93%) | 5 (1.81%) | 1.0 |
| Malignancy | 20 (5%) | 5 (4.63%) | 15 (5.43%) | 1.0 |
| Neuropsychiatric disease | 30 (8%) | 12 (11.11%) | 18 (6.52%) | 0.14 |
| Rheumatological disease | 8 (2.08%) | 0 (0%) | 8 (2.90%) | 0.11 |
| Smoking | 23 (6%) | 6 (5.56%) | 17 (6.16%) | 1.0 |
IQR – Interquartile range